Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in TauP301L-BiFC mice
Article in Experimental & Molecular Medicine (March 2023)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Experimental & Molecular Medicine (March 2023)
Preprint in Research Square (August 2022)
Article in The Journal of Physiology (June 2022)